ProfileGDS5822 / ILMN_1231573
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 95% 92% 93% 95% 93% 93% 95% 96% 92% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 11192.495
GSM1276600PDAC Late Ablation Control 2669.792
GSM1276601PDAC Late Ablation Control 3913.793
GSM1276602PDAC Late Ablation 11205.995
GSM1276603PDAC Late Ablation 2846.193
GSM1276604PDAC Late Ablation 3830.193
GSM1303940PDAC Late Ablation_anti-CTLA4 11246.595
GSM1303941PDAC Late Ablation_anti-CTLA4 21515.896
GSM1303942PDAC Late Ablation_anti-CTLA4 3794.592